Centessa Pharmaceuticals plc (CNTA)

Centessa Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	44.24	383.22	128.03	393.64	595.08	7.23
Short-Term Investments	206.48	98.96	128.52	-	-	-
Cash & Short-Term Investments	250.72	482.18	256.55	393.64	595.08	7.23
Cash Growth	-14.96%	87.95%	-34.83%	-33.85%	8134.15%	-
Other Receivables	44.1	45.3	39.15	26.72	16.81	2.93
Receivables	44.1	45.3	39.15	26.72	16.81	2.93
Prepaid Expenses	0.23	0.84	1.65	2.79	4.66	0.01
Other Current Assets	5.31	8.1	17.74	14.59	12.22	1
Total Current Assets	300.36	536.41	315.09	437.75	628.77	11.17
Property, Plant & Equipment	11.27	11.76	12.95	1.17	0.16	-
Long-Term Deferred Tax Assets	25.37	26.59	29.65	3.51	-	-
Other Long-Term Assets	1.72	2.05	2.55	1.88	0.7	0.55
Total Assets	492.13	576.8	360.25	444.31	629.64	11.72
Accounts Payable	5.69	7.14	11.82	13.84	8.07	1.03
Accrued Expenses	22.94	49.31	26.62	22.23	15.7	1.04
Short-Term Debt	-	-	-	-	-	5.63
Current Portion of Leases	0.66	0.6	-	-	-	-
Current Income Taxes Payable	0.26	0.84	0.11	1.58	0.77	-
Other Current Liabilities	0.15	0.11	0.84	0.69	0.1	0.92
Total Current Liabilities	29.69	58	39.39	38.34	24.64	8.62
Long-Term Debt	109.55	108.94	75.7	69.8	75.7	-
Long-Term Leases	7.94	8.29	8.89	-	-	-
Other Long-Term Liabilities	0.03	0.03	0.03	-	37.74	-
Total Liabilities	147.21	175.25	124	108.14	138.08	8.62
Common Stock	0.36	0.36	0.27	0.27	0.25	25.55
Additional Paid-In Capital	1,408	1,386	987.42	939.26	876.27	0.83
Retained Earnings	-1,065	-988.7	-752.95	-601.86	-385.65	-23.85
Comprehensive Income & Other	1.59	4.21	1.49	-1.5	0.69	0.57
Shareholders' Equity	344.92	401.55	236.24	336.17	491.55	3.1
Total Liabilities & Equity	492.13	576.8	360.25	444.31	629.64	11.72
Total Debt	118.14	117.83	84.59	69.8	75.7	5.63
Net Cash (Debt)	132.58	364.35	171.96	323.84	519.38	1.6
Net Cash Growth	-36.62%	111.88%	-46.90%	-37.65%	32361.38%	-
Net Cash Per Share	1.03	3.18	1.79	3.47	6.91	0.11
Filing Date Shares Outstanding	134.07	133.18	100.31	94.96	94.02	15
Total Common Shares Outstanding	133.91	132.63	98.77	94.84	89.99	15
Working Capital	270.67	478.41	275.71	399.41	604.14	2.55
Book Value Per Share	2.58	3.03	2.39	3.54	5.46	0.21
Tangible Book Value	344.92	401.55	236.24	336.17	491.55	3.1
Tangible Book Value Per Share	2.58	3.03	2.39	3.54	5.46	0.21
Machinery	1.62	1.54	1.5	0.44	0.2	-
Construction In Progress	-	-	-	0.89	-	-

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q